Hello and Welcome to Patientsville.com, Your Source for all METHIMAZOLE information. We are dedicated to provide You with METHIMAZOLE safety information. Learn about METHIMAZOLE serious adverse events reported to Food and Drug Administration (FDA).
Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
METHIMAZOLE Safety Reports
Total METHIMAZOLE reports: 37.METHIMAZOLE FDA safety alerts: No.
Reported deaths: 2 Reported hospitalizations: 24.
Take METHIMAZOLE Side Effects Survey or Share Your METHIMAZOLE Story. Read More Here.
Consumer or non-health professional from UNITED STATES reported METHIMAZOLE problem on June 21, 2006. Female patient, 42 years of age, was diagnosed with basedow's disease and was treated with METHIMAZOLE. After drug was administered, patient experienced the following problems/side effects: agranulocytosis. METHIMAZOLE dosage: 40 MG, QD; PO. Patient was hospitalized. Patient recovered.
METHIMAZOLE problem was reported by a Physician from UNITED STATES on June 21, 2006. Female patient, 36 years of age, was diagnosed with hyperthyroidism and was treated with METHIMAZOLE. After drug was administered, patient experienced the following problems/side effects: hepatotoxicity. METHIMAZOLE dosage: 40 MG (20 MG, 2 IN 1 D);. Patient was hospitalized. Patient recovered.
Physician from UNITED STATES reported METHIMAZOLE problem on June 21, 2006. Female patient, 75 years of age, was diagnosed with hyperthyroidism and was treated with METHIMAZOLE. After drug was administered, patient experienced the following problems/side effects: jaundice cholestatic. METHIMAZOLE dosage: 40MG (10 MG, 4 IN 1 D);. Patient was hospitalized. Patient recovered.
METHIMAZOLE problem was reported by a Physician from UNITED STATES on June 21, 2006. Female patient, 74 years of age, was diagnosed with hyperthyroidism and was treated with METHIMAZOLE. After drug was administered, patient experienced the following problems/side effects: jaundice cholestatic. METHIMAZOLE dosage: 40MG (10 MG, 4 IN 1 D);. Patient was hospitalized. Patient recovered.
Physician from UNITED STATES reported METHIMAZOLE problem on June 21, 2006. Male patient, 68 years of age, was diagnosed with hyperthyroidism and was treated with METHIMAZOLE. After drug was administered, patient experienced the following problems/side effects: jaundice cholestatic. METHIMAZOLE dosage: 60MG (20MG, 3 IN 1 D);. Patient was hospitalized. Patient recovered.
METHIMAZOLE problem was reported by a Physician from UNITED STATES on June 21, 2006. Female patient, 43 years of age, was diagnosed with hyperthyroidism and was treated with METHIMAZOLE. After drug was administered, patient experienced the following problems/side effects: jaundice cholestatic. METHIMAZOLE dosage: 30MG (10 MG, 3 IN 1 D);. During the same period patient was treated with PROPRANOLOL, AMLODIPINE. Patient was hospitalized. Patient recovered.
Physician from UNITED STATES reported METHIMAZOLE problem on June 21, 2006. Female patient, 58 years of age, was diagnosed with hyperthyroidism and was treated with METHIMAZOLE. After drug was administered, patient experienced the following problems/side effects: jaundice cholestatic. METHIMAZOLE dosage: 20MG (20 MG, 1 IN 1 D);. Patient was hospitalized. Patient recovered.
METHIMAZOLE problem was reported by a Physician from UNITED STATES on June 21, 2006. Female patient, 62 years of age, was diagnosed with hyperthyroidism and was treated with METHIMAZOLE. After drug was administered, patient experienced the following problems/side effects: jaundice cholestatic. METHIMAZOLE dosage: 40 MG (10 MG, 4 IN 1 D);. Patient was hospitalized. Patient recovered.
Physician from UNITED STATES reported METHIMAZOLE problem on June 21, 2006. Female patient, 36 years of age, was diagnosed with hyperthyroidism and was treated with METHIMAZOLE. After drug was administered, patient experienced the following problems/side effects: jaundice cholestatic. METHIMAZOLE dosage: 60MG (15 MG, 4 IN 1 D);. Patient was hospitalized. Patient recovered.
METHIMAZOLE problem was reported by a Physician from UNITED STATES on June 21, 2006. Female patient, 63 years of age, was diagnosed with hyperthyroidism and was treated with METHIMAZOLE. After drug was administered, patient experienced the following problems/side effects: jaundice cholestatic. METHIMAZOLE dosage: 60 MG (15 MG, 4 IN 1 D);. Patient was hospitalized. Patient recovered.
Physician from UNITED STATES reported METHIMAZOLE problem on June 21, 2006. Female patient, 38 years of age, was diagnosed with hyperthyroidism and was treated with METHIMAZOLE. After drug was administered, patient experienced the following problems/side effects: jaundice cholestatic. METHIMAZOLE dosage: 20MG (20 MG, 1 IN 1 D);. Patient was hospitalized. Patient recovered.
METHIMAZOLE problem was reported by a Physician from UNITED STATES on June 21, 2006. Female patient, 54 years of age, was diagnosed with hyperthyroidism and was treated with METHIMAZOLE. After drug was administered, patient experienced the following problems/side effects: jaundice cholestatic. METHIMAZOLE dosage: 40 MG, (40 MG, 1 IN 1 D);. Patient was hospitalized. Patient recovered.
Physician from UNITED STATES reported METHIMAZOLE problem on June 21, 2006. Female patient, 54 years of age, was diagnosed with hyperthyroidism and was treated with METHIMAZOLE. After drug was administered, patient experienced the following problems/side effects: jaundice cholestatic. METHIMAZOLE dosage: 40 MG (40 MG, 1 IN 1 D);. Patient was hospitalized. Patient recovered.
METHIMAZOLE problem was reported by a Consumer or non-health professional from UNITED STATES on July 27, 2006. Male patient, 35 years of age, weighting 165.0 lb, was diagnosed with basedow's disease and was treated with METHIMAZOLE. After drug was administered, patient experienced the following problems/side effects: weight increased. METHIMAZOLE dosage: 5 MG, QD; PO. Patient recovered.
Physician from UNITED STATES reported METHIMAZOLE problem on July 28, 2006. Male patient, 54 years of age, was diagnosed with basedow's disease, atrial fibrillation and was treated with METHIMAZOLE. After drug was administered, patient experienced the following problems/side effects: international normalised ratio. METHIMAZOLE dosage: unknown. During the same period patient was treated with WARFARIN, METOPROLOL SUCCINATE, DEXAMETHASONE. Patient recovered.
METHIMAZOLE problem was reported by a Physician from ITALY on June 21, 2006. Male patient was diagnosed with basedow's disease and was treated with METHIMAZOLE. After drug was administered, patient experienced the following problems/side effects: caesarean section, congenital anomaly, developmental delay, exomphalos, premature separation of placenta, skull malformation, treatment noncompliance, twin pregnancy. METHIMAZOLE dosage: 40,000 MG (40 MG, 1 IN 1 D); 20,000 MG (20 MG, 1 IN 1 D) TRANSPLACENTAL MATERNAL USE. During the same period patient was treated with PROPRANOLOL, HALOPERINDOL. Patient recovered.
Physician from ITALY reported METHIMAZOLE problem on June 21, 2006. Female patient was diagnosed with basedow's disease and was treated with METHIMAZOLE. After drug was administered, patient experienced the following problems/side effects: aplasia, choanal atresia, congenital genitourinary abnormality, eyelid disorder, hypertonia neonatal, pilonidal cyst, premature baby, skull malformation. METHIMAZOLE dosage: 10,000 MG (10 MG, 1 IN 1 D) TRANSPLACENTAL MATERNAL USE. Patient recovered.
METHIMAZOLE problem was reported by a Physician from HUNGARY on June 21, 2006. Female patient, child 1 years of age, was diagnosed with hyperthyroidism and was treated with METHIMAZOLE. After drug was administered, patient experienced the following problems/side effects: alopecia, aplasia cutis congenita, bone scan abnormal, dysmorphism, premature baby, scar, skull malformation. METHIMAZOLE dosage: 40,000 MG (40 MG, 1 IN 1 D) TRANSPLACENTAL MATERNAL USE. Patient recovered.
Physician from JAPAN reported METHIMAZOLE problem on June 21, 2006. Female patient, 53 years of age, was treated with METHIMAZOLE. After drug was administered, patient experienced the following problems/side effects: aplastic anaemia, blood calcium decreased, bone marrow failure, bone marrow plasmacyte count increased, goitre, hypokalaemia, immunodeficiency, palpitations, pharyngolaryngeal pain. METHIMAZOLE dosage: unknown. Patient was hospitalized. Patient recovered.
METHIMAZOLE problem was reported by a Consumer or non-health professional from JAPAN on June 21, 2006. Male patient was treated with METHIMAZOLE. After drug was administered, patient experienced the following problems/side effects: aplasia cutis congenita, bone development abnormal, skin lesion. METHIMAZOLE dosage: unknown. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from JAPAN reported METHIMAZOLE problem on June 21, 2006. Female patient was diagnosed with basedow's disease and was treated with METHIMAZOLE. After drug was administered, patient experienced the following problems/side effects: aplasia, caesarean section, congenital intestinal malformation, foetal growth retardation, gallbladder anomaly congenital, iris coloboma, microcornea, nipple disorder. METHIMAZOLE dosage: unknown. Patient was hospitalized. Patient died.
METHIMAZOLE problem was reported by a Consumer or non-health professional from ARGENTINA on July 07, 2006. Female patient was treated with METHIMAZOLE. After drug was administered, patient experienced the following problems/side effects: apgar score low, caesarean section, choanal atresia, congenital nose malformation, congenital oral malformation, high arched palate, premature baby, skull malformation. METHIMAZOLE dosage: 15 MG (15MG, 1 IN 1 D). During the same period patient was treated with LEVOTHYROXINE. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from ARGENTINA reported METHIMAZOLE problem on July 07, 2006. Female patient was treated with METHIMAZOLE. After drug was administered, patient experienced the following problems/side effects: apgar score low, caesarean section, choanal atresia, congenital nose malformation, congenital oral malformation, high arched palate, premature baby, skull malformation. METHIMAZOLE dosage: 15 MG (15 MG, 1 IN 1 D). During the same period patient was treated with LEVOTHYROXINE. Patient was hospitalized. Patient recovered.
METHIMAZOLE problem was reported by a Consumer or non-health professional from ARGENTINA on July 07, 2006. Female patient was treated with METHIMAZOLE. After drug was administered, patient experienced the following problems/side effects: abnormal palmar/plantar creases, choanal atresia, congenital nose malformation, intubation complication, micrognathia, skull malformation. METHIMAZOLE dosage: 20 MG (20 MG, 1 IN 1 D). Patient was hospitalized. Patient recovered.
Consumer or non-health professional from ITALY reported METHIMAZOLE problem on July 07, 2006. Male patient was treated with METHIMAZOLE. After drug was administered, patient experienced the following problems/side effects: abasia, abnormal palmar/plantar creases, body height below normal, brain hypoxia, caesarean section, cerebral ischaemia, charge syndrome, choanal atresia, congenital anomaly. METHIMAZOLE dosage: 20 MG (5 MG, 4 IN 1 D) TRANSPLACENTAL. Patient recovered.
METHIMAZOLE problem was reported by a Pharmacist from UNITED STATES on July 31, 2006. Female patient, 40 years of age, was diagnosed with hyperthyroidism and was treated with METHIMAZOLE. After drug was administered, patient experienced the following problems/side effects: gastrointestinal necrosis, genital pain female, granulocytopenia, hypotension, oedema genital, pharyngolaryngeal pain, septic shock, soft tissue infection, tachycardia. METHIMAZOLE dosage: unknown. During the same period patient was treated with METOPROLOL TARTRATE. Patient died.
Pharmacist from UNITED STATES reported METHIMAZOLE problem on Aug 22, 2006. Female patient, 49 years of age, was treated with METHIMAZOLE. After drug was administered, patient experienced the following problems/side effects: febrile neutropenia, granulocytopenia. METHIMAZOLE dosage: 20MG B.I.D. PO. During the same period patient was treated with ATENOLOL, ZYRTEC. Patient was hospitalized. Patient recovered.
METHIMAZOLE problem was reported by a Health Professional from UNITED STATES on Aug 14, 2006. Male patient, 28 years of age, was diagnosed with basedow's disease and was treated with METHIMAZOLE. After drug was administered, patient experienced the following problems/side effects: blood alkaline phosphatase increased, blood bilirubin increased, cholestasis, jaundice, pruritus. METHIMAZOLE dosage: 10 MG, TID. During the same period patient was treated with PROPRANOLOL. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from UNITED STATES reported METHIMAZOLE problem on Aug 25, 2006. Female patient, 36 years of age, weighting 110.2 lb, was diagnosed with hyperthyroidism and was treated with METHIMAZOLE. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase abnormal, cholestasis. METHIMAZOLE dosage: 20 MG , BID. During the same period patient was treated with PROPRANOLOL HYDROCHLORIDE. Patient recovered.
METHIMAZOLE problem was reported by a Physician from ITALY on Aug 25, 2006. Female patient, 34 years of age, was diagnosed with basedow's disease and was treated with METHIMAZOLE. After drug was administered, patient experienced the following problems/side effects: caesarean section, premature labour, premature separation of placenta, twin pregnancy. METHIMAZOLE dosage: 40 MG/DAY, 20 MG/DAY. During the same period patient was treated with PROPRANOLOL, HALOPERIDOL. Patient recovered.
Physician from ITALY reported METHIMAZOLE problem on Aug 25, 2006. Male patient was treated with METHIMAZOLE. After drug was administered, patient experienced the following problems/side effects: abdominal wall disorder, caesarean section, developmental delay, exomphalos, motor dysfunction, premature baby, skin disorder. METHIMAZOLE dosage: unknown. Patient recovered.
METHIMAZOLE problem was reported by a Physician from ITALY on Aug 25, 2006. Male patient was treated with METHIMAZOLE. After drug was administered, patient experienced the following problems/side effects: caesarean section, premature baby. METHIMAZOLE dosage: unknown. Patient recovered.
Consumer or non-health professional from POLAND reported METHIMAZOLE problem on Nov 16, 2006. Female patient, child 12 years of age, was diagnosed with hyperthyroidism and was treated with METHIMAZOLE. After drug was administered, patient experienced the following problems/side effects: biopsy kidney abnormal, collagen disorder, hypothyroidism, influenza like illness, leukopenia, raynaud's phenomenon, stomatitis, toxic epidermal necrolysis, transaminases increased. METHIMAZOLE dosage: 0.8 MG/KG DAILY. Patient was hospitalized. Patient recovered.
METHIMAZOLE problem was reported by a Consumer or non-health professional from UNITED STATES on Nov 17, 2006. Male patient, 42 years of age, was diagnosed with hyperthyroidism and was treated with METHIMAZOLE. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, basedow's disease, gastrointestinal haemorrhage, hyperbilirubinaemia, post procedural complication, transaminases increased. METHIMAZOLE dosage: 30 MG Q6HR-IV. During the same period patient was treated with HYDROCORTISONE. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from UNITED STATES reported METHIMAZOLE problem on Dec 13, 2006. Female patient, 15 years of age, was diagnosed with hyperthyroidism and was treated with METHIMAZOLE. After drug was administered, patient experienced the following problems/side effects: antineutrophil cytoplasmic antibody positive, antinuclear antibody positive, blood blister, eschar, leukocytoclastic vasculitis, malaise, pyrexia, skin necrosis, urticaria. METHIMAZOLE dosage: unknown. Patient recovered.
METHIMAZOLE problem was reported by a Consumer or non-health professional from UNITED STATES on Dec 12, 2006. Female patient, 18 years of age, was diagnosed with hyperthyroidism and was treated with METHIMAZOLE. After drug was administered, patient experienced the following problems/side effects: antineutrophil cytoplasmic antibody positive, pulmonary vasculitis, respiratory failure, systemic lupus erythematosus. METHIMAZOLE dosage: unknown. Patient recovered.
Pharmacist from UNITED STATES reported METHIMAZOLE problem on Aug 23, 2007. Female patient, 34 years of age, was treated with METHIMAZOLE. After drug was administered, patient experienced the following problems/side effects: cholestasis, hypothyroidism, lichenoid keratosis, thyrotoxic crisis. METHIMAZOLE dosage: unknown. During the same period patient was treated with PROPRANOLOL. Patient was hospitalized. Patient recovered.